Publication:
Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia

dc.contributor.authorsBudak-Alpdogan, T; Alpdogan, O; Akoglu, T
dc.date.accessioned2022-03-14T10:56:42Z
dc.date.accessioned2026-01-11T17:47:13Z
dc.date.available2022-03-14T10:56:42Z
dc.date.issued1999-12
dc.description.abstractClonogenic capacity of bone marrow progenitors and stromal layers established from bone marrow of 12 patients with CML and 13 healthy controls were evaluated. The initial BFU-E and CFU-GM contents were slightly higher in the CML patients (p > 0.05) in contrast to CFU-GEMM. CFU-GEMM was lower in the patients compared to healthy controls (p < 0.001). In long-term cultures, the number of non-adherent cell population and total clonogenic progenitor cell content decreased gradually in both groups. Weekly evaluation of stromal confluency of adherent cells revealed that establishment of adherent stromal layer was slower in CML patients than in control samples (p < 0.05). At the end of fourth week, the number of samples presenting confluency was 41.7% in the CML group compared with 92.3% in the controls. The initial CD34 positive cell content of the bone marrow samples was similar in both groups. Although CD34 positive cell number in the adherent stromal layer was well preserved in the control group at the end of 4 weeks, this figure decreased significantly in the CML group. The numbers of total adherent cells as well as the total clonogenic progenitor content of adherent layer were also lower in the CML group (3.03% vs 98.2%). When normal CD34+ cells were cultured on IFN-alpha-treated stromal layer followed by the assessment of the long-term culture initiating cells, a reduced capacity to support hemopoietic growth was observed with IFN-alpha-treated normal stroma. This reduction was even higher when CML stroma was treated with IFN-a followed by the seeding of the normal CD34+ cells on this stromal layer (26.9% vs 42.8%). These findings show that stromal cells are abnormal in CML patients as well as the progenitor cells, and IFN-alpha treatment causes further defects of the stromal cells. (C) 1999 Wiley-Liss, Inc.
dc.identifier.doi10.1002/(SICI)1096-8652(199912)62:4<212::AID-AJH3>3.0.CO;2-S
dc.identifier.eissn1096-8652
dc.identifier.issn0361-8609
dc.identifier.pubmed10589076
dc.identifier.urihttps://hdl.handle.net/11424/245549
dc.identifier.wosWOS:000084033600003
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofAMERICAN JOURNAL OF HEMATOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectchronic myelogenous leukemia
dc.subjectinterferon-alpha
dc.subjectlong-term bone marrow culture
dc.subjectclonogenic assay
dc.subjectCHRONIC MYELOID-LEUKEMIA
dc.subjectINTERFERON-ALPHA RESTORES
dc.subjectPRIMITIVE HEMATOPOIETIC PROGENITORS
dc.subjectCOLONY-STIMULATING FACTOR
dc.subjectSTROMAL CELLS
dc.subjectRECEPTOR ANTAGONIST
dc.subjectCHRONIC-PHASE
dc.subjectSTEM-CELL
dc.subjectHLA-DR
dc.subjectGRANULOCYTE
dc.titleMorphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage220
oaire.citation.issue4
oaire.citation.startPage212
oaire.citation.titleAMERICAN JOURNAL OF HEMATOLOGY
oaire.citation.volume62

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
349.16 KB
Format:
Adobe Portable Document Format